Stoke Therapeutics (STOK) Other financing activities (2018 - 2026)

Stoke Therapeutics' Other financing activities history runs 9 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Other financing activities rose 219.22% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $10.8 million (up 336.35% YoY), while the FY2025 annual figure was $8.6 million, up 399.59% from the prior year.
• Other financing activities for Q1 2026 stood at $3.2 million, down from $7.6 million in the prior quarter.
• The five-year high for Other financing activities was $7.6 million in Q4 2025, with the low at -$634000.0 in Q2 2025.
• The 5-year median for Other financing activities is $161000.0 (2023), against an average of $851235.3.
• The sharpest annual moves came in 2024 and 2025: Other financing activities jumped 29650.0% in 2024, then sank 673.17% in 2025.
• Stoke Therapeutics' Other financing activities stood at $118000.0 in 2022, then tumbled by 96.61% to $4000.0 in 2023, then surged by 29650.0% to $1.2 million in 2024, then surged by 538.74% to $7.6 million in 2025, then plunged by 57.83% to $3.2 million in 2026.
• Business Quant data shows STOK's Other financing activities at $3.2 million in Q1 2026, $7.6 million in Q4 2025, and $632000.0 in Q3 2025.